Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma.
about
Venous thromboembolic diseaseApplying a highly specific and reproducible cDNA RDA method to clone garlic up-regulated genes in human gastric cancer cellsConstruction of HCV-core gene vector and its expression in cholangiocarcinomaEffect of arsenic trioxide on rat hepatocellular carcinoma and its renal cytotoxityPreparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization.Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany.Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early hepatocellular carcinoma in patients with cirrhosis.The prognostic significance of clinical and pathological features in hepatocellular carcinoma.Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits.Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial.Local recurrence is an important prognostic factor of hepatocellular carcinoma.Autoimmune conditions are associated with perioperative thrombotic complications in liver transplant recipients: A UNOS database analysis.Therapeutic polypeptides based on HBV core 18-27 epitope can induce CD8+ CTL-mediated cytotoxicity in HLA-A2+ human PBMCs.Fos expression in tyrosine hydroxylase-containing neurons in rat brainstem after visceral noxious stimulation: an immunohistochemical studyPrevalence of hepatitis B and C markers among refugees in Athens.Gene expression profiles of hepatoma cell line HLE.Glycylproline dipeptidyl aminopeptidase isoenzyme in diagnosis of primary hepatocellular carcinoma.Effects of hepatitis B virus infection on human sperm chromosomes.Preparation and characterization of polyclonal antibodies against ARL-1 protein.Transarterial chemoembolization with/without cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinomaTherapeutic polypeptides based on HBcAg(18-27) CTL epitope can induce antigen-specific CD(8)(+) CTL-mediated cytotoxicity in HLA-A2 transgenic mice.Lethiferous effects of a recombinant vector carrying thymidine kinase suicide gene on 2.2.15 cells via a self-modulating mechanism.High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.Hepatitis B- and hepatitis C-related hepatocellular carcinomas in the United States: similarities and differencesEffects of Zhaoyangwan on chronic hepatitis B and posthepatic cirrhosis.Establishment of mice model with human viral hepatitis B.Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patientsIncidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma.Surgical resection of recurrent extrahepatic hepatocellular carcinoma with tumor thrombus extending into the right atrium under cardiopulmonary bypass: a case report and review of the literatureRole of preoperative selective portal vein embolization in two-step curative hepatectomy for hepatocellular carcinoma.DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line.Safe upper limit of intermittent hepatic inflow occlusion for liver resection in cirrhotic rats.Effects of PPARg agonist pioglitazone on rat hepatic fibrosis.Construction and expression of recombined human AFP eukaryotic expression vector.Reversible phospho-Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection.Thrombosis after liver transplantation for hepatocellular carcinoma.
P2860
Q24631121-A4883464-AF33-45ED-AA35-4A4908334ACCQ28211769-E8BF2060-1498-4F65-ADB5-470026F9DC75Q30724292-40B69531-708A-4AE6-B3DC-9DE70F56871DQ30921046-A3BBD75B-7D95-484D-A180-16015AE9F0A1Q31114066-62EEB006-C4B3-43FE-8445-AB1100CDDC9CQ33951214-D36D1A01-D0CA-45C0-9648-C6709DBBF447Q34325161-6F7C4684-7438-448B-AE4E-4A5A7EFC4DAFQ34582844-46A6784C-7ADD-47B9-9F60-165EBC519CBBQ35010543-679271AE-5AEA-4C66-8444-DBE94C2384A2Q35621231-0979C86B-35C2-4973-B394-54280352EFF2Q35784062-5F223116-6317-42A2-A737-BEB1A7A23CAFQ36024830-BC6B8D89-EE5F-499D-B22F-AE6C0E8C8B40Q36065876-729D1C82-CFEA-4BD5-B7A3-3F77B6B39693Q36178449-18E710E3-D988-4FE6-A0B5-868A3BF49D23Q36178581-ADFB1050-BB14-47D6-B29A-037A7635A14EQ36178624-C9762E32-D994-4B8B-AF97-F2B828DDF4ABQ36178658-9249ACBC-A04E-402F-9B24-8B339163EB9FQ36178675-69DC341B-8960-4210-A5DF-296A32DC88CFQ36190630-13508F96-0A5B-4FB3-BAE3-1F6EC4DB7D19Q36285672-1C2D7336-A970-4CD8-B0AC-52269129C898Q36308346-363DA708-4E68-43B1-87E2-D32FC5180E1BQ36308663-C81E2A6A-914C-4DB3-A886-25C9A7B6077FQ36309132-D91E8DB9-332C-4C71-BFD4-EA405C1EAF18Q36316052-0E73161B-ACD5-4D74-889D-BAE355DD8AE0Q36454775-75569819-FF0A-4127-8592-5EEA362AD89AQ36474447-97E40EB0-C342-4A48-9A2D-6F4734BE5255Q36502579-DC784906-C9C0-4200-8F15-14FE6C4653F0Q36615885-32432135-AAD5-4982-B360-E3C7B98D74AAQ36812718-27F2E172-83D4-4EFC-8654-7A14AB0FF749Q38977514-48C0938A-14A4-4AE9-B9B6-8F4BB54B2631Q40552306-069D3DAF-47C8-4110-AE28-112E3A154276Q40697710-A431E4C1-5A7E-4C04-A312-1DED9EDE0A4CQ41513376-04ABD75E-F941-481E-A20A-1331FD82BA78Q41908629-B9EF60CC-9D56-42ED-96F0-0AF610CC7982Q41983590-B8440E32-B98D-4A7F-9627-D6CFF4586E0DQ42246559-D0F22027-5940-4419-8BFD-938E7DCD5DD0Q43026378-19A8DCF5-28F8-4820-976C-B6D26080CCAF
P2860
Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical characteristics and o ...... with hepatocellular carcinoma.
@ast
Clinical characteristics and o ...... with hepatocellular carcinoma.
@en
Clinical characteristics and o ...... with hepatocellular carcinoma.
@nl
type
label
Clinical characteristics and o ...... with hepatocellular carcinoma.
@ast
Clinical characteristics and o ...... with hepatocellular carcinoma.
@en
Clinical characteristics and o ...... with hepatocellular carcinoma.
@nl
prefLabel
Clinical characteristics and o ...... with hepatocellular carcinoma.
@ast
Clinical characteristics and o ...... with hepatocellular carcinoma.
@en
Clinical characteristics and o ...... with hepatocellular carcinoma.
@nl
P2093
P2860
P1476
Clinical characteristics and o ...... with hepatocellular carcinoma.
@en
P2093
C Klostermann
H H Schild
T Sauerbruch
W H Caselmann
P2860
P304
P407
P577
2001-04-01T00:00:00Z